Jpmorgan Chase & Co »

Kezar Life Sciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Kezar Life Sciences (KZR) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Kezar Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kezar Life Sciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kezar Life Sciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $814 209 3.90
2025-03-31 $809 166 4.88
2024-12-31 $80k 12k 6.72

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Kezar Life Sciences

BML Capital Management
Tang Capital Management
Suvretta Capital Management
Stonepine Capital Management
Vanguard Group
OrbiMed Advisors
Acadian Asset Management
Peapod Lane Capital
ADAR1 Capital Management
Renaissance Technologies
Ikarian Capital
BlackRock
Qiming U.S. Ventures Management
Shay Capital
Geode Capital Management

View all funds holding Kezar Life Sciences